Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?

Annals of surgical oncology(2023)

引用 0|浏览26
暂无评分
摘要
None of the TSC-PNET patients recurred after a median follow-up of 78.0 months. The risk-benefit of aggressive pancreatic operations in TSC-PNET patients is still unclear and our findings suggest a conservative approach should be considered.
更多
查看译文
关键词
Pancreatic neuroendocrine tumor, PNET, Tuberous sclerosis complex syndrome, TSC, Outcomes, mTOR inhibitor, Pancreatic lesion
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要